메뉴 건너뛰기




Volumn 26, Issue 1, 2007, Pages 61-70

Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma

Author keywords

Capecitabine; Neoadjuvant chemoradiation; Rectal tumor

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID;

EID: 34247465427     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (67)
  • 1
    • 0033984573 scopus 로고    scopus 로고
    • Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial
    • Bosset J.F., Magnin V., Maingon P., et al.: Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int. J. Radiat. Oncol. Biol. Phys. 46: 323-327, 2000.
    • (2000) Int. J. Radiat. Oncol. Biol. Phys , vol.46 , pp. 323-327
    • Bosset, J.F.1    Magnin, V.2    Maingon, P.3
  • 2
    • 0029057685 scopus 로고
    • Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum
    • Chari R.S., Tyler D.S., Anscher M.S., et al.: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann. Surg. 221: 778-786, 1995.
    • (1995) Ann. Surg , vol.221 , pp. 778-786
    • Chari, R.S.1    Tyler, D.S.2    Anscher, M.S.3
  • 3
    • 0028115401 scopus 로고
    • Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer
    • Minsky B., Cohen A.M., Enker W., et al.: Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 73: 273-280, 1994.
    • (1994) Cancer , vol.73 , pp. 273-280
    • Minsky, B.1    Cohen, A.M.2    Enker, W.3
  • 4
    • 0029093508 scopus 로고
    • Preoperative infusional chemoradiation therapy for stage T3 rectal cancer
    • Rich T.A., Skibber J.M., Ajani J.A., et al.: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:1025-1029, 1995.
    • (1995) Int. J. Radiat. Oncol. Biol. Phys , vol.32 , pp. 1025-1029
    • Rich, T.A.1    Skibber, J.M.2    Ajani, J.A.3
  • 5
    • 31844451549 scopus 로고    scopus 로고
    • Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival
    • Wiltshire K.L., Ward I.G., Swallow C., et al.: Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int. J. Radiat. Oncol. Biol. Phys. 64:709-16, 2006.
    • (2006) Int. J. Radiat. Oncol. Biol. Phys , vol.64 , pp. 709-716
    • Wiltshire, K.L.1    Ward, I.G.2    Swallow, C.3
  • 6
    • 0028136295 scopus 로고
    • Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
    • O'Connell M.J., Martenson J.A., Wieand H.S., et al.: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N. Engl. J. Med. 331: 502-507, 1994.
    • (1994) N. Engl. J. Med , vol.331 , pp. 502-507
    • O'Connell, M.J.1    Martenson, J.A.2    Wieand, H.S.3
  • 7
    • 0029020530 scopus 로고
    • Concomitant radiochemo-therapy in rectal cancer: Methodology and indications
    • Valentini V., Luzi S., Mantini G., Turriziani A., Cellini N.: Concomitant radiochemo-therapy in rectal cancer: methodology and indications. Rays 20: 90-111, 1995.
    • (1995) Rays , vol.20 , pp. 90-111
    • Valentini, V.1    Luzi, S.2    Mantini, G.3    Turriziani, A.4    Cellini, N.5
  • 8
    • 0031471150 scopus 로고    scopus 로고
    • Systemic treatment options in advanced colorectal cancer: Perspectives on combination 5-fluorouracil plus leucovorin
    • Grem J.L.: Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin. Semin. Oncol. 24 (Suppl. 18): 8-18, 1997.
    • (1997) Semin. Oncol , vol.24 , Issue.SUPPL. 18 , pp. 8-18
    • Grem, J.L.1
  • 9
    • 0032127244 scopus 로고    scopus 로고
    • Design of a novel oral fluoropyrimidinecarbamate capecitabine, wich generates 5-fluorouracilselectively in tumours by enzymes concentrated in human liver and cancer tissue
    • Miwa M., Ura M., Nishida M., et al.: Design of a novel oral fluoropyrimidinecarbamate capecitabine, wich generates 5-fluorouracilselectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur. J. Cancer 34: 1274-1281, 1998.
    • (1998) Eur. J. Cancer , vol.34 , pp. 1274-1281
    • Miwa, M.1    Ura, M.2    Nishida, M.3
  • 10
    • 0032695102 scopus 로고    scopus 로고
    • X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenograft
    • Sawada N., Ishikawa T., Sekiguchi F., Tanaka Y., Ishitsuka H.: X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenograft. Clin. Cancer Res. 5: 2948-2953, 1999.
    • (1999) Clin. Cancer Res , vol.5 , pp. 2948-2953
    • Sawada, N.1    Ishikawa, T.2    Sekiguchi, F.3    Tanaka, Y.4    Ishitsuka, H.5
  • 11
    • 0036177692 scopus 로고    scopus 로고
    • Future treatment options with capecitabine in solid tumors
    • Wilke H.: Future treatment options with capecitabine in solid tumors. Eur. J. Cancer 38 (Suppl. 2): 21-25, 2002.
    • (2002) Eur. J. Cancer , vol.38 , Issue.SUPPL. 2 , pp. 21-25
    • Wilke, H.1
  • 12
    • 0035690103 scopus 로고    scopus 로고
    • Capecitabine: A review of its use in the treatment of advanced or metastatic colorectal cancer
    • McGavin J.K., Goa K.L.: Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer. Drugs 61:2309-2326, 2001.
    • (2001) Drugs , vol.61 , pp. 2309-2326
    • McGavin, J.K.1    Goa, K.L.2
  • 13
    • 33646450317 scopus 로고    scopus 로고
    • Capecitabine in the treatment of colorectal cancer
    • O'Neill V.J., Cassidy J.: Capecitabine in the treatment of colorectal cancer. Future Oncol. 1:183-90, 2005.
    • (2005) Future Oncol , vol.1 , pp. 183-190
    • O'Neill, V.J.1    Cassidy, J.2
  • 14
    • 0034745284 scopus 로고    scopus 로고
    • The Xeloda Colorectal Cancer Study Group: Capecitabine (Xeloda) improves medical resource use compared with 5 fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma
    • Twelves C., Boyer M., Findlay M., et al. : The Xeloda Colorectal Cancer Study Group: Capecitabine (Xeloda) improves medical resource use compared with 5 fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. Eur. J. Cancer 37: 597-604, 2001.
    • (2001) Eur. J. Cancer , vol.37 , pp. 597-604
    • Twelves, C.1    Boyer, M.2    Findlay, M.3
  • 15
    • 0035871538 scopus 로고    scopus 로고
    • Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
    • Hoff P.M., Ansari M., Batist G., et al.: Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J. Clin. Oncol. 19: 2282-2292, 2001.
    • (2001) J. Clin. Oncol , vol.19 , pp. 2282-2292
    • Hoff, P.M.1    Ansari, M.2    Batist, G.3
  • 16
    • 2442535083 scopus 로고    scopus 로고
    • Intensity modulate radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer
    • Ben-Josef E., Shields A.F., Vaishanpayan U., et al.: Intensity modulate radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 59: 454-459, 2004.
    • (2004) Int. J. Radiat. Oncol. Biol. Phys , vol.59 , pp. 454-459
    • Ben-Josef, E.1    Shields, A.F.2    Vaishanpayan, U.3
  • 17
    • 0036643954 scopus 로고    scopus 로고
    • A single institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies
    • Vaishampayan U.N., Ben-Josef E., Philip P.A., et al.: A single institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int. J. Radiat. Oncol. Biol. Phys. 53, 675-679, 2002.
    • (2002) Int. J. Radiat. Oncol. Biol. Phys , vol.53 , pp. 675-679
    • Vaishampayan, U.N.1    Ben-Josef, E.2    Philip, P.A.3
  • 18
    • 33644968733 scopus 로고    scopus 로고
    • Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    • Lee H.S., Choi Y., Hur W.J., et al. : Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabine. World J. Gastroenterol. 12:603-7, 2006.
    • (2006) World J. Gastroenterol , vol.12 , pp. 603-607
    • Lee, H.S.1    Choi, Y.2    Hur, W.J.3
  • 19
    • 0037827307 scopus 로고    scopus 로고
    • Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer
    • Souglakos J., Androulakis N., Mavroudis D., et al.: Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 56: 1284-1287, 2003.
    • (2003) Int. J. Radiat. Oncol. Biol. Phys , vol.56 , pp. 1284-1287
    • Souglakos, J.1    Androulakis, N.2    Mavroudis, D.3
  • 20
    • 31844452408 scopus 로고    scopus 로고
    • A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer
    • Jin J., Li Y.X., Liu Y.P., et al. : A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 64:725-729, 2006.
    • (2006) Int. J. Radiat. Oncol. Biol. Phys , vol.64 , pp. 725-729
    • Jin, J.1    Li, Y.X.2    Liu, Y.P.3
  • 21
    • 33645100321 scopus 로고    scopus 로고
    • Capecitabine chemoradiation for rectal cancer after curative surgery
    • Bajetta E., Beretta E., Di Bartolomeo M., et al.: Capecitabine chemoradiation for rectal cancer after curative surgery. J. Chemother. 18:85-9, 2006.
    • (2006) J. Chemother , vol.18 , pp. 85-89
    • Bajetta, E.1    Beretta, E.2    Di Bartolomeo, M.3
  • 22
    • 0142041932 scopus 로고    scopus 로고
    • Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: Rationale, preliminary results and perspectives
    • Corvò R., Pastrone I., Scolaro T., Mercenaro M., Berretta L., Chiara S. : Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives. Tumori 89: 361-367, 2003.
    • (2003) Tumori , vol.89 , pp. 361-367
    • Corvò, R.1    Pastrone, I.2    Scolaro, T.3    Mercenaro, M.4    Berretta, L.5    Chiara, S.6
  • 23
    • 0036804343 scopus 로고    scopus 로고
    • Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer
    • Kim J.S., Kim J., Cho M.J., Song K.S., Yoon W.H.: Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 54: 403-408, 2002.
    • (2002) Int. J. Radiat. Oncol. Biol. Phys , vol.54 , pp. 403-408
    • Kim, J.S.1    Kim, J.2    Cho, M.J.3    Song, K.S.4    Yoon, W.H.5
  • 24
    • 0034176245 scopus 로고    scopus 로고
    • Trotti A, Byhardt R, Stetz J, et al, Common toxicity criteria: version 2.0. An improved reference for grading the acute effects on cancer treatment: impact on radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 47: 13-47, 2000
    • Trotti A., Byhardt R., Stetz J., et al.: Common toxicity criteria: version 2.0. An improved reference for grading the acute effects on cancer treatment: impact on radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 47: 13-47, 2000.
  • 25
    • 0028305674 scopus 로고
    • Pathologic assessment of tumor regression after preoperative chemoradiotherapy for esophageal carcinoma
    • Mandard A.M., Dalibard F., Manyard J.C., et al.: Pathologic assessment of tumor regression after preoperative chemoradiotherapy for esophageal carcinoma. Cancer 73: 2680-2686, 1994.
    • (1994) Cancer , vol.73 , pp. 2680-2686
    • Mandard, A.M.1    Dalibard, F.2    Manyard, J.C.3
  • 26
    • 33845382806 scopus 로고
    • Non parametric extimation from incomplete observations
    • Kaplan E.L., Meier P.: Non parametric extimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-481, 1958.
    • (1958) J. Am. Stat. Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 27
    • 24944534960 scopus 로고    scopus 로고
    • Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate
    • Folkesson J., Birgisson H., Pahlman L., Cedermark B., Glimelius B., Gunnarsson U.: Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J. Clin. Oncol. 23: 5644-5650, 2005.
    • (2005) J. Clin. Oncol , vol.23 , pp. 5644-5650
    • Folkesson, J.1    Birgisson, H.2    Pahlman, L.3    Cedermark, B.4    Glimelius, B.5    Gunnarsson, U.6
  • 28
    • 0035975394 scopus 로고    scopus 로고
    • Dutch Colorectal Cancer Group: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
    • Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al.: Dutch Colorectal Cancer Group: preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 345: 638-646, 2001.
    • (2001) N. Engl. J. Med , vol.345 , pp. 638-646
    • Kapiteijn, E.1    Marijnen, C.A.2    Nagtegaal, I.D.3
  • 29
    • 33644845287 scopus 로고    scopus 로고
    • Swedish Rectal Cancer Trial Group. Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial
    • Birgisson H., Pahlman L., Gunnarsson U., Glimelius B.: Swedish Rectal Cancer Trial Group. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J. Clin. Oncol. 23:8697-705, 2005.
    • (2005) J. Clin. Oncol , vol.23 , pp. 8697-8705
    • Birgisson, H.1    Pahlman, L.2    Gunnarsson, U.3    Glimelius, B.4
  • 30
    • 25844523989 scopus 로고    scopus 로고
    • Polish Colorectal Study Group. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: Results of a randomised trial: implication for subsequent local excision
    • Bujko K., Nowacki M.P, Nasierowska-Guttmejer A., et al.: Polish Colorectal Study Group. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother. Oncol. 2005 76:234-40.
    • (2005) Radiother. Oncol , vol.76 , pp. 234-240
    • Bujko, K.1    Nowacki, M.P.2    Nasierowska-Guttmejer, A.3
  • 31
    • 6044226542 scopus 로고    scopus 로고
    • Sauer R., Becker H., Hohenberger W., and German Rectal Cancer Study Group.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351:1731-40, 2004.
    • Sauer R., Becker H., Hohenberger W., and German Rectal Cancer Study Group.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351:1731-40, 2004.
  • 32
    • 24944499364 scopus 로고    scopus 로고
    • Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results-EORTC 22921
    • Bosset J.F., Calais G., Mineur L., et al.: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J. Clin. Oncol. 23:5620-5627, 2005.
    • (2005) J. Clin. Oncol , vol.23 , pp. 5620-5627
    • Bosset, J.F.1    Calais, G.2    Mineur, L.3
  • 33
    • 30944457098 scopus 로고    scopus 로고
    • Pre-operative chemo-radiotherapy improves local control in T3-4 rectal cancers: Results of the FFCD 9203 randomized trial
    • Abstr
    • Gerard J., Romestaing P., Bonnetain F., et al. : Pre-operative chemo-radiotherapy improves local control in T3-4 rectal cancers: results of the FFCD 9203 randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 63 (Suppl. 1):S2 (Abstr.), 2005.
    • (2005) Int. J. Radiat. Oncol. Biol. Phys , vol.63 , Issue.SUPPL. 1
    • Gerard, J.1    Romestaing, P.2    Bonnetain, F.3
  • 34
    • 2942648695 scopus 로고    scopus 로고
    • Four decades of continuing innovation with fluorouracil: Current and future approaches to fluorouracil chemoradiation therapy
    • Rich T., Shepard RC., Mosley S.T.: Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. J. Clin. Oncol. 22: 2214-2232, 2004.
    • (2004) J. Clin. Oncol , vol.22 , pp. 2214-2232
    • Rich, T.1    Shepard, R.C.2    Mosley, S.T.3
  • 35
    • 0344109583 scopus 로고    scopus 로고
    • Efficacy of intravenous continous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
    • Meta-analysis Group in cancer
    • Meta-analysis Group in cancer: Efficacy of intravenous continous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J. Clin. Oncol. 16: 301-308, 1998.
    • (1998) J. Clin. Oncol , vol.16 , pp. 301-308
  • 36
    • 0031431131 scopus 로고    scopus 로고
    • 5Fluorouracil (5FU) continuous intravenous infusion compared with bolus administration. Final results of a randomized trial in metastatic colorectal cancer
    • Rougier P., Pailloty B., LaPlanche A. , et al.: 5Fluorouracil (5FU) continuous intravenous infusion compared with bolus administration. Final results of a randomized trial in metastatic colorectal cancer. Eur. J. Cancer 33: 1789-1983, 1997
    • (1997) Eur. J. Cancer , vol.33 , pp. 1789-1983
    • Rougier, P.1    Pailloty, B.2    LaPlanche, A.3
  • 37
    • 21244497388 scopus 로고    scopus 로고
    • Capecitabine as adjuvant treatment for stage III colon cancer
    • Twelves C., Wong A., Nowacki M.P., et al.: Capecitabine as adjuvant treatment for stage III colon cancer. N. Engl. J. Med. 35:2696-704, 2005.
    • (2005) N. Engl. J. Med , vol.35 , pp. 2696-2704
    • Twelves, C.1    Wong, A.2    Nowacki, M.P.3
  • 38
    • 0030810428 scopus 로고    scopus 로고
    • Irradiation plus 5-fluorouracil: Cellular mechanisms of action and treatment schedule
    • Rich T.A.: Irradiation plus 5-fluorouracil: cellular mechanisms of action and treatment schedule. Semin. Radiat. Oncol. 7: 267-273, 1997.
    • (1997) Semin. Radiat. Oncol , vol.7 , pp. 267-273
    • Rich, T.A.1
  • 39
    • 31544483550 scopus 로고    scopus 로고
    • Pharmacoeconomic analysis of oral capecitabine in the adjuvant setting. Resuts from the X-ACT trial comparing capecitabine with i.v. 5-FU/LV in patients with Dukes'C colon cancer
    • Abstr
    • Douillard .JY., Twelves C., Mc Kendrick J.F., et al: Pharmacoeconomic analysis of oral capecitabine in the adjuvant setting. Resuts from the X-ACT trial comparing capecitabine with i.v. 5-FU/LV in patients with Dukes'C colon cancer. Ann. Oncol. 15 (Suppl. 3): s112 (Abstr.), 2004.
    • (2004) Ann. Oncol , vol.15 , Issue.SUPPL. 3
    • Douillard, J.Y.1    Twelves, C.2    Mc Kendrick, J.F.3
  • 40
    • 2342624007 scopus 로고    scopus 로고
    • Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands
    • Jansman F.G., Postma M.J., van Hartskamp D., Willemse P.H., Brouwers J.R.: Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands. Clin. Ther. 26: 579-589, 2004.
    • (2004) Clin. Ther , vol.26 , pp. 579-589
    • Jansman, F.G.1    Postma, M.J.2    van Hartskamp, D.3    Willemse, P.H.4    Brouwers, J.R.5
  • 41
    • 4444346434 scopus 로고    scopus 로고
    • Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advanced colorectal cancer
    • Abstr
    • James R., Bianco C., Farina C.: Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advanced colorectal cancer. Eur. J. Cancer 39 (Suppl. 5): s83 (Abstr.), 2003.
    • (2003) Eur. J. Cancer , vol.39 , Issue.SUPPL. 5
    • James, R.1    Bianco, C.2    Farina, C.3
  • 42
    • 0031017851 scopus 로고    scopus 로고
    • Patient preferences for oral versus intravenous palliative chemotherapy
    • Liu G., Fransse E., Fitch M., Warner E. : Patient preferences for oral versus intravenous palliative chemotherapy. J. Clin. Oncol. 15:110-115, 1997.
    • (1997) J. Clin. Oncol , vol.15 , pp. 110-115
    • Liu, G.1    Fransse, E.2    Fitch, M.3    Warner, E.4
  • 43
    • 0036159485 scopus 로고    scopus 로고
    • Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial in advanced colorectal cancer
    • Borner M.M., Schoffski P., de Wit R., et al.: Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur. J. Cancer 38: 349-358, 2002.
    • (2002) Eur. J. Cancer , vol.38 , pp. 349-358
    • Borner, M.M.1    Schoffski, P.2    de Wit, R.3
  • 44
    • 0036787579 scopus 로고    scopus 로고
    • Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer
    • Dunst J., Reese T., Sutter T., et al.: Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J. Clin. Oncol. 20: 3983-3991, 2002.
    • (2002) J. Clin. Oncol , vol.20 , pp. 3983-3991
    • Dunst, J.1    Reese, T.2    Sutter, T.3
  • 45
    • 5044220099 scopus 로고    scopus 로고
    • A phase I trial of preoperative radiotherapy and capecitabine for locally advanced rectal cancer
    • Ngan S.Y.K., Michael M., Mackay J., et al. : A phase I trial of preoperative radiotherapy and capecitabine for locally advanced rectal cancer. Br. J. Cancer 91: 1019-1024, 2004.
    • (2004) Br. J. Cancer , vol.91 , pp. 1019-1024
    • Ngan, S.Y.K.1    Michael, M.2    Mackay, J.3
  • 46
    • 34247520247 scopus 로고    scopus 로고
    • Preoperative Capecitabine (X) chemoradiation is effective and well tolerated in patients with locally advanced rectal cancer (LARC): Findings from a phase I dose-escalation study
    • Abstr
    • Veerasarn V., Phronratanapongse P., Lorvidhaya V., et al.: Preoperative Capecitabine (X) chemoradiation is effective and well tolerated in patients with locally advanced rectal cancer (LARC): findings from a phase I dose-escalation study. Radiother. Oncol. 73 (Suppl. 1): s267 (Abstr.), 2004.
    • (2004) Radiother. Oncol , vol.73 , Issue.SUPPL. 1
    • Veerasarn, V.1    Phronratanapongse, P.2    Lorvidhaya, V.3
  • 47
    • 31544461568 scopus 로고    scopus 로고
    • Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: A multicentric phase II study
    • De Paoli A., Chiara S., Luppi G., et al.: Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann. Oncol. 17:246-51, 2006
    • (2006) Ann. Oncol , vol.17 , pp. 246-251
    • De Paoli, A.1    Chiara, S.2    Luppi, G.3
  • 48
    • 34247474038 scopus 로고    scopus 로고
    • Prospective phase II study of preoperative radiotherapy and oral capecitabine followed by total mesorectal excision (TME) in locally advanced rectal cancer
    • Abstr
    • Kim J.H., Park J.H., Choi E.K., et al.: Prospective phase II study of preoperative radiotherapy and oral capecitabine followed by total mesorectal excision (TME) in locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 60 (Suppl. 1): s425 (Abstr.), 2004.
    • (2004) Int. J. Radiat. Oncol. Biol. Phys , vol.60 , Issue.SUPPL. 1
    • Kim, J.H.1    Park, J.H.2    Choi, E.K.3
  • 49
    • 24944563286 scopus 로고    scopus 로고
    • Capecitabine (C) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: A phase II GERCOR trial
    • Abstr
    • Dupuis B., Vie G., Lledo C., et al: Capecitabine (C) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: a phase II GERCOR trial. J. Clin. Oncol. 22 (Suppl. 14): s254 (Abstr.), 2004.
    • (2004) J. Clin. Oncol , vol.22 , Issue.SUPPL. 14
    • Dupuis, B.1    Vie, G.2    Lledo, C.3
  • 50
    • 34247469505 scopus 로고    scopus 로고
    • Altered fractionation chemoradiotherapy for locally advanced rectal cancer
    • Washington, Abstr
    • Zubyk S., Fuller C.D., Kahlenberg M.S., et al.: Altered fractionation chemoradiotherapy for locally advanced rectal cancer. Gastrointestinal Cancer Symposium, Washington 39 (Abstr.), 2004.
    • (2004) Gastrointestinal Cancer Symposium , pp. 39
    • Zubyk, S.1    Fuller, C.D.2    Kahlenberg, M.S.3
  • 51
    • 33644696400 scopus 로고    scopus 로고
    • Phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients (pts) with locally advanced rectal cancer (LARC)
    • s, Abstr
    • Lin .EH., Skibber J., Delcos M., et al.: Phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients (pts) with locally advanced rectal cancer (LARC). J. Clin. Oncol. 23, (Suppl. 1): s 3593 (Abstr.), 2005.
    • (2005) J. Clin. Oncol , vol.23 , Issue.SUPPL. 1 , pp. 3593
    • Lin, E.H.1    Skibber, J.2    Delcos, M.3
  • 52
    • 34247489887 scopus 로고    scopus 로고
    • Sefr R., Kocakova I., Penka I. et al.: Preoperative radiotherapy and oral capecitabine improve surgical results in patients with locally advanced mid-lower rectal cancer. Eur. J. Cancer Suppl 3/2: s201 (Abstr.), 2005.
    • Sefr R., Kocakova I., Penka I. et al.: Preoperative radiotherapy and oral capecitabine improve surgical results in patients with locally advanced mid-lower rectal cancer. Eur. J. Cancer Suppl 3/2: s201 (Abstr.), 2005.
  • 53
    • 4444302024 scopus 로고    scopus 로고
    • Phase-II-study of preoperative chemoradiation with capecitabine in rectal cancer
    • Dunst J., Reese T., Debus J. et al.: Phase-II-study of preoperative chemoradiation with capecitabine in rectal cancer. J. Clin. Oncol. 22 (Suppl. 14): s259, 2004.
    • (2004) J. Clin. Oncol , vol.22 , Issue.SUPPL. 14
    • Dunst, J.1    Reese, T.2    Debus, J.3
  • 54
    • 0032783898 scopus 로고    scopus 로고
    • Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer
    • Janjan N.A., Khoo V.S., Abbruzzese J., et al.: Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 44: 1027-1038, 1999.
    • (1999) Int. J. Radiat. Oncol. Biol. Phys , vol.44 , pp. 1027-1038
    • Janjan, N.A.1    Khoo, V.S.2    Abbruzzese, J.3
  • 55
    • 0043067010 scopus 로고    scopus 로고
    • The addition of continuous infusion of 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer
    • Crane C.H., Skibber J.N., Birnbaum E.H., et al. : The addition of continuous infusion of 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 57: 84-89, 2003.
    • (2003) Int. J. Radiat. Oncol. Biol. Phys , vol.57 , pp. 84-89
    • Crane, C.H.1    Skibber, J.N.2    Birnbaum, E.H.3
  • 57
    • 33744472470 scopus 로고    scopus 로고
    • Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil
    • Yerushalmi R., Idelevich E., Dror Y., et al. : Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil. J. Surg. Oncol. 93:529-33, 2006
    • (2006) J. Surg. Oncol , vol.93 , pp. 529-533
    • Yerushalmi, R.1    Idelevich, E.2    Dror, Y.3
  • 58
    • 33646236446 scopus 로고    scopus 로고
    • Neoadjuvant Chemoradiation with Capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: A matched pair analysis
    • Abstr
    • Das P., Lin E.H., Bhatia S., et al: Neoadjuvant Chemoradiation with Capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: a matched pair analysis. Int. J. Radiat. Oncol. Phys. 63 (Suppl.1): s164 (Abstr.), 2005.
    • (2005) Int. J. Radiat. Oncol. Phys , vol.63 , Issue.SUPPL.1
    • Das, P.1    Lin, E.H.2    Bhatia, S.3
  • 59
    • 33144459846 scopus 로고    scopus 로고
    • Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer
    • Kim J.S., Kim J.S., Cho M.J., Yoon W.H., Song K.S. :Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. J. Korean Med. Sci. 21:52-7, 2006
    • (2006) J. Korean Med. Sci , vol.21 , pp. 52-57
    • Kim, J.S.1    Kim, J.S.2    Cho, M.J.3    Yoon, W.H.4    Song, K.S.5
  • 60
    • 29844435015 scopus 로고    scopus 로고
    • A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
    • Glynne-Jones R., Sebag-Montefiore D., Maughan T.S., Falk S.J., McDonald A.C.: A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann. Oncol. 17: 50-56, 2006.
    • (2006) Ann. Oncol , vol.17 , pp. 50-56
    • Glynne-Jones, R.1    Sebag-Montefiore, D.2    Maughan, T.S.3    Falk, S.J.4    McDonald, A.C.5
  • 61
    • 20144375332 scopus 로고    scopus 로고
    • Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer
    • Hofheinz R.D., von Gerstemberg-Helldorf B., Wenz F., et al.: Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J. Clin. Oncol. 23: 1350-1357, 2005.
    • (2005) J. Clin. Oncol , vol.23 , pp. 1350-1357
    • Hofheinz, R.D.1    von Gerstemberg-Helldorf, B.2    Wenz, F.3
  • 62
    • 33645728850 scopus 로고    scopus 로고
    • Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: Results from a phase I/II study
    • Klautke G., Kuchenmeister U., Foitzik T., et al. : Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br. J. Cancer. 94:976-81, 2006
    • (2006) Br. J. Cancer , vol.94 , pp. 976-981
    • Klautke, G.1    Kuchenmeister, U.2    Foitzik, T.3
  • 63
    • 28444461463 scopus 로고    scopus 로고
    • Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study
    • Machiels J.P., Duck L., Honhon B., et al.: Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann. Oncol. 16:1898-905, 2005.
    • (2005) Ann. Oncol , vol.16 , pp. 1898-1905
    • Machiels, J.P.1    Duck, L.2    Honhon, B.3
  • 64
    • 33644846344 scopus 로고    scopus 로고
    • Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer
    • Chau I., Brown G., Cunningham D., et al.: Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J. Clin. Oncol. 24:668-74, 2006.
    • (2006) J. Clin. Oncol , vol.24 , pp. 668-674
    • Chau, I.1    Brown, G.2    Cunningham, D.3
  • 65
    • 25844442570 scopus 로고    scopus 로고
    • The multidisciplinary rectal cancer treatment: Main convergences, controversial aspects and investigational areas which support the need for an European Consensus
    • Valentini V., Glimelius B., Minsky BD., et al. : The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother. Oncol. 76:241-50, 2005.
    • (2005) Radiother. Oncol , vol.76 , pp. 241-250
    • Valentini, V.1    Glimelius, B.2    Minsky, B.D.3
  • 66
    • 0041379454 scopus 로고    scopus 로고
    • Neoadjuvant radiochemotherapy treatment in locally advanced rectal adenocarcinoma
    • Carau B., Orrù. P. Orrù S., et al: Neoadjuvant radiochemotherapy treatment in locally advanced rectal adenocarcinoma. Tumori. 89 (Suppl.4): s7-8, 2003.
    • (2003) Tumori , vol.89 , Issue.SUPPL.4
    • Carau, B.1    Orrù, P.2    Orrù, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.